MedPath

A comparison between Percutaneous Vertebroplasty procedure and Teriparatide injection in management of vertebral compression fracture, resulting from bone mineral loss.

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/10/058456
Lead Sponsor
Institue of Postgraduate Medical Education and Research SSKM Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient diagnosed as Osteoporosis as per WHO criteria [T score of
2. Vertebral compression fracture on spine radiograph (minimum height loss 15%).

3. Low back pain for last 6 months or less.

4. Visual analogue scale (VAS) score > 3.

5. Bone edema of vertebral fracture on MRI.

Exclusion Criteria

1. Spinal instability

2. Radicular pain or Radiculopathy

3. Abnormal coagulation profile

4. Systemic or local infection

5. Severe cardio-pulmonary comorbidities, uncontrolled liver and kidney diseases

6. Uncontrolled Diabetes mellitus

7. Underlying malignant disease

8. Loss of vertebral height =80% or vertebra plana, pedicle fracture, burst fracture and Scoliosis

9. Greater than 3 compression fractures

10. Patient’s refusal

11. Allergy to local anesthetic or PMMA, or Teriparatide.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath